CS368890A3 - Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them - Google Patents

Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them

Info

Publication number
CS368890A3
CS368890A3 CS903688A CS368890A CS368890A3 CS 368890 A3 CS368890 A3 CS 368890A3 CS 903688 A CS903688 A CS 903688A CS 368890 A CS368890 A CS 368890A CS 368890 A3 CS368890 A3 CS 368890A3
Authority
CS
Czechoslovakia
Prior art keywords
preparation
aminooligohydroxy
renin
inhibiting effects
pharmaceutical containing
Prior art date
Application number
CS903688A
Other languages
English (en)
Inventor
Heinz-Werner Dr Kleemann
Hansjorg Dr Urbach
Adalbert Dr Wagner
Dieter Dr Ruppert
Wolfgang Dr Linz
Werner Dr Krames
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3924506A external-priority patent/DE3924506A1/de
Priority claimed from DE19893932817 external-priority patent/DE3932817A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CS368890A3 publication Critical patent/CS368890A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
CS903688A 1989-07-25 1990-07-24 Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them CS368890A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3924506A DE3924506A1 (de) 1989-07-25 1989-07-25 Renin-hemmende aminooligohydroxy-derivate
DE19893932817 DE3932817A1 (de) 1989-09-30 1989-09-30 Renin-hemmende aminooligohydroxy-derivate

Publications (1)

Publication Number Publication Date
CS368890A3 true CS368890A3 (en) 1992-02-19

Family

ID=25883333

Family Applications (1)

Application Number Title Priority Date Filing Date
CS903688A CS368890A3 (en) 1989-07-25 1990-07-24 Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them

Country Status (20)

Country Link
EP (1) EP0410278B1 (cs)
JP (1) JPH0366652A (cs)
KR (1) KR910002776A (cs)
CN (1) CN1049164A (cs)
AT (1) ATE100463T1 (cs)
AU (1) AU639246B2 (cs)
CA (1) CA2021822A1 (cs)
CS (1) CS368890A3 (cs)
DE (1) DE59004292D1 (cs)
DK (1) DK0410278T3 (cs)
ES (1) ES2062214T3 (cs)
FI (1) FI903701A0 (cs)
HU (1) HU205140B (cs)
IE (1) IE902686A1 (cs)
IL (1) IL95166A0 (cs)
MA (1) MA21913A1 (cs)
NO (1) NO903291L (cs)
NZ (1) NZ234608A (cs)
PL (1) PL286188A1 (cs)
PT (1) PT94798A (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209870B (cs) * 1990-01-18 1993-07-21 Pfizer
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
JPH06500561A (ja) * 1990-08-24 1994-01-20 ジ・アップジョン・カンパニー 遷移状態模擬体としてのアミノポリオール含有ペプチド
EP0483403A1 (en) * 1990-10-31 1992-05-06 Hoechst Aktiengesellschaft Derivatives of amino acids as inhibitors of renin, methods for their preparation, medicaments containing them and their use
CA2404644A1 (en) * 2000-04-10 2001-10-18 Yuichi Ishida Modulators of prorenin activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK34086A (da) * 1985-01-23 1986-07-24 Abbott Lab Peptidylaminodioler
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
US4863905A (en) * 1987-02-04 1989-09-05 Warner-Lambert Company Renin inhibitors II

Also Published As

Publication number Publication date
CN1049164A (zh) 1991-02-13
CA2021822A1 (en) 1991-01-26
KR910002776A (ko) 1991-02-26
PT94798A (pt) 1991-03-20
HU205140B (en) 1992-03-30
HUT55033A (en) 1991-04-29
AU5971990A (en) 1991-01-31
NZ234608A (en) 1991-12-23
DK0410278T3 (da) 1994-05-24
ES2062214T3 (es) 1994-12-16
HU904582D0 (en) 1990-12-28
NO903291D0 (no) 1990-07-24
NO903291L (no) 1991-01-28
EP0410278A1 (de) 1991-01-30
PL286188A1 (en) 1991-04-22
AU639246B2 (en) 1993-07-22
DE59004292D1 (de) 1994-03-03
IL95166A0 (en) 1991-06-10
ATE100463T1 (de) 1994-02-15
FI903701A0 (fi) 1990-07-23
MA21913A1 (fr) 1991-04-01
EP0410278B1 (de) 1994-01-19
IE902686A1 (en) 1991-02-27
JPH0366652A (ja) 1991-03-22

Similar Documents

Publication Publication Date Title
ZA926276B (en) 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.
IL102759A0 (en) Hydantoin derivatives,their preparation and pharmaceutical compositions containing them
ZA926328B (en) Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them.
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
IL90804A0 (en) Diphosphonic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
GR3029406T3 (en) Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them.
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GR3025268T3 (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
GR3023934T3 (en) New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
CS368890A3 (en) Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them
HU903811D0 (en) Process for producing dibenzo (1,5)dioxocine-5-one derivatives and pharmaceutical preparatives containing such compounds
ZA942964B (en) Pyrrolopyrazine compounds processes for their preparation and the pharmaceutical compositions which contain them
ZA941196B (en) Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them
ES2049186A1 (es) Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol.
IL104444A0 (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides,their preparation and pharmaceutical compositions containing them
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
HU9302778D0 (en) Process for preparing acyl-sulfonamido-and sulfonamido-pyridine-2-carboxylic acid esters and pharmaceutical compositions containing them
IL106934A (en) Heteroarenylpiperazines a process for their preparation and pharmaceutical compositions comprising them
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them